Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]

Cristian Rodriguez-Aguayo; Emine Bayraktar; Cristina Ivan; Burcu Aslan; Junhua Mai; Guangan He; Lingegowda S. Mangala; Dahai Jiang; Archana S. Nagaraja; Bulent Ozpolat; Arturo Chavez-Reyes; Mauro Ferrari; Rahul Mitra; Zahid H. Siddik; Haifa Shen; Xianbin Yang; Anil K. Sood; Gabriel Lopez-Berestein

doi:10.1016/j.ebiom.2022.104194

Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]

Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, Burcu Aslan, Junhua Mai, Guangan He, Lingegowda S. Mangala, Dahai Jiang, Archana S. Nagaraja, Bulent Ozpolat, Arturo Chavez-Reyes, Mauro Ferrari, Rahul Mitra, Zahid H. Siddik, Haifa Shen, Xianbin Yang, Anil K. Sood, Gabriel Lopez-Berestein

Research output: Contribution to journal › Article › peer-review

Abstract

The authors noticed that in Figure 6B, the TUNEL staining panel for the “PTGER3 siRNA” group was inadvertently duplicated in the next position for the group of “2’F-PS2-PTGER3 siRNA”. Below is the corrected version of Figure 6B TUNEL staining panels with a new representative image for the 2’F-PS2-PTGER3 siRNA group. This change does not affect the results or conclusions. The authors apologize for any inconvenience caused.

Original language	English (US)
Article number	104194
Pages (from-to)	104194
Journal	EBioMedicine
Volume	83
DOIs	https://doi.org/10.1016/j.ebiom.2022.104194
State	Published - Sep 2022

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1016/j.ebiom.2022.104194

Cite this

Rodriguez-Aguayo, C., Bayraktar, E., Ivan, C., Aslan, B., Mai, J., He, G., Mangala, L. S., Jiang, D., Nagaraja, A. S., Ozpolat, B., Chavez-Reyes, A., Ferrari, M., Mitra, R., Siddik, Z. H., Shen, H., Yang, X., Sood, A. K., & Lopez-Berestein, G. (2022). Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]. EBioMedicine, 83, 104194. Article 104194. https://doi.org/10.1016/j.ebiom.2022.104194

Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]. / Rodriguez-Aguayo, Cristian; Bayraktar, Emine; Ivan, Cristina et al.
In: EBioMedicine, Vol. 83, 104194, 09.2022, p. 104194.

Research output: Contribution to journal › Article › peer-review

Rodriguez-Aguayo, C, Bayraktar, E, Ivan, C, Aslan, B, Mai, J, He, G, Mangala, LS, Jiang, D, Nagaraja, AS, Ozpolat, B, Chavez-Reyes, A, Ferrari, M, Mitra, R, Siddik, ZH, Shen, H, Yang, X, Sood, AK & Lopez-Berestein, G 2022, 'Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]', EBioMedicine, vol. 83, 104194, pp. 104194. https://doi.org/10.1016/j.ebiom.2022.104194

@article{8bf826c6fe9547d5bc6d8982f8c2f466,

title = "Corrigendum to {"}PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis{"} [EBioMedicine 40 (2019) 290-304]",

abstract = "The authors noticed that in Figure 6B, the TUNEL staining panel for the “PTGER3 siRNA” group was inadvertently duplicated in the next position for the group of “2{\textquoteright}F-PS2-PTGER3 siRNA”. Below is the corrected version of Figure 6B TUNEL staining panels with a new representative image for the 2{\textquoteright}F-PS2-PTGER3 siRNA group. This change does not affect the results or conclusions. The authors apologize for any inconvenience caused.",

author = "Cristian Rodriguez-Aguayo and Emine Bayraktar and Cristina Ivan and Burcu Aslan and Junhua Mai and Guangan He and Mangala, {Lingegowda S.} and Dahai Jiang and Nagaraja, {Archana S.} and Bulent Ozpolat and Arturo Chavez-Reyes and Mauro Ferrari and Rahul Mitra and Siddik, {Zahid H.} and Haifa Shen and Xianbin Yang and Sood, {Anil K.} and Gabriel Lopez-Berestein",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = sep,

doi = "10.1016/j.ebiom.2022.104194",

language = "English (US)",

volume = "83",

pages = "104194",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]

AU - Rodriguez-Aguayo, Cristian

AU - Bayraktar, Emine

AU - Ivan, Cristina

AU - Aslan, Burcu

AU - Mai, Junhua

AU - He, Guangan

AU - Mangala, Lingegowda S.

AU - Jiang, Dahai

AU - Nagaraja, Archana S.

AU - Ozpolat, Bulent

AU - Chavez-Reyes, Arturo

AU - Ferrari, Mauro

AU - Mitra, Rahul

AU - Siddik, Zahid H.

AU - Shen, Haifa

AU - Yang, Xianbin

AU - Sood, Anil K.

AU - Lopez-Berestein, Gabriel

PY - 2022/9

Y1 - 2022/9

N2 - The authors noticed that in Figure 6B, the TUNEL staining panel for the “PTGER3 siRNA” group was inadvertently duplicated in the next position for the group of “2’F-PS2-PTGER3 siRNA”. Below is the corrected version of Figure 6B TUNEL staining panels with a new representative image for the 2’F-PS2-PTGER3 siRNA group. This change does not affect the results or conclusions. The authors apologize for any inconvenience caused.

AB - The authors noticed that in Figure 6B, the TUNEL staining panel for the “PTGER3 siRNA” group was inadvertently duplicated in the next position for the group of “2’F-PS2-PTGER3 siRNA”. Below is the corrected version of Figure 6B TUNEL staining panels with a new representative image for the 2’F-PS2-PTGER3 siRNA group. This change does not affect the results or conclusions. The authors apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85135114960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85135114960&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2022.104194

DO - 10.1016/j.ebiom.2022.104194

M3 - Article

C2 - 35914489

AN - SCOPUS:85135114960

SN - 2352-3964

VL - 83

SP - 104194

JO - EBioMedicine

JF - EBioMedicine

M1 - 104194

ER -

Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this